TARDBP and Alzheimer disease: In addition, donors were also assessed for several hallmarks of non-AD pathology including both α-synuclein pathology using Braak LB staging30 (mean = 1.34, SD = 2.26) and TDP-43 status (127 (22%) of 590 tested donors were classified as TDP-43 positive).